Musculoskeletal
1 drug is in development for Knee Osteoarthritis.
- Companies
- 1
- Clinical trials
- 37
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Knee Osteoarthritis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| allojoin | CELLULAR BIOMEDICINE GROUP, INC. (CMBG) |
About this indication
Knee Osteoarthritis context
Musculoskeletal·MeSH: Osteoarthritis, Knee (D020370)
Also known as: Knee Osteoarthritides, Osteoarthritis of Knee, Osteoarthritis of the Knee
Prevalence
10000.0 / 100K
Incidence
600.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Knee Osteoarthritis?
BioSniper tracks 1 drug in development for Knee Osteoarthritis across 1 company.
How many clinical trials target Knee Osteoarthritis?
There are 37 clinical trials targeting Knee Osteoarthritis tracked by BioSniper.
What is the prevalence of Knee Osteoarthritis?
The estimated prevalence of Knee Osteoarthritis is approximately 10000.0 per 100,000 population.